Novartis Says EMA CHMP Gives Positive Opinion for Cosentyx
Novartis said the EMA CHMP adopted a positive opinion recommending marketing authorization for Cosentyx.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.